Alcohol Addiction Therapeutics Market Report

Global and Region Alcohol Addiction Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：172
  • REPORT CODE：GMM929812
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Alcohol Addiction Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Alcohol Addiction Therapeuticsmarket, defines the market attractiveness level of Alcohol Addiction Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Alcohol Addiction Therapeutics industry, describes the types of Alcohol Addiction Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alcohol Addiction Therapeutics market and the development prospects and opportunities of Alcohol Addiction Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alcohol Addiction Therapeutics market in Chapter 13.

    By Player:

    • Chronos Therapeutics Ltd

    • Eli Lilly and Company

    • Cerecor Inc

    • BioCorRx Inc

    • Bionex Pharmaceuticals LLC

    • Curemark LLC

    • Omeros Corp

    • Kyorin Pharmaceutical Co Ltd

    • Ethypharm SA

    • Opiant Pharmaceuticals Inc

    • Lohocla Research Corp

    • Montisera Ltd

    • Kinnov Therapeutics SAS

    • Indivior Plc

    • Corcept Therapeutics Inc

    • Heptares Therapeutics Ltd

    • AstraZeneca Plc

    • H Lundbeck A/S

    By Type:

    • CM-1212

    • CTDP-002

    • A-705253

    • ABT-436

    • ADX-71441

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Alcohol Addiction Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Alcohol Addiction Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Alcohol Addiction Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Alcohol Addiction Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Alcohol Addiction Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 7.2 United States Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 7.3 Europe Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 7.4 China Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 7.5 Japan Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 7.6 India Alcohol Addiction Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Alcohol Addiction Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Alcohol Addiction Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Alcohol Addiction Therapeutics Consumption Forecast (2022-2028)

    9 Global Alcohol Addiction Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Alcohol Addiction Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CM-1212 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CTDP-002 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global A-705253 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ABT-436 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global ADX-71441 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Alcohol Addiction Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Alcohol Addiction Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CM-1212 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CTDP-002 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global A-705253 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global ABT-436 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global ADX-71441 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Alcohol Addiction Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Alcohol Addiction Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Alcohol Addiction Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Alcohol Addiction Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Alcohol Addiction Therapeutics Market Competitive Analysis

    • 14.1 Chronos Therapeutics Ltd

      • 14.1.1 Chronos Therapeutics Ltd Company Details

      • 14.1.2 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product and Service

    • 14.2 Eli Lilly and Company

      • 14.2.1 Eli Lilly and Company Company Details

      • 14.2.2 Eli Lilly and Company Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Eli Lilly and Company Alcohol Addiction Therapeutics Product and Service

    • 14.3 Cerecor Inc

      • 14.3.1 Cerecor Inc Company Details

      • 14.3.2 Cerecor Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Cerecor Inc Alcohol Addiction Therapeutics Product and Service

    • 14.4 BioCorRx Inc

      • 14.4.1 BioCorRx Inc Company Details

      • 14.4.2 BioCorRx Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 BioCorRx Inc Alcohol Addiction Therapeutics Product and Service

    • 14.5 Bionex Pharmaceuticals LLC

      • 14.5.1 Bionex Pharmaceuticals LLC Company Details

      • 14.5.2 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product and Service

    • 14.6 Curemark LLC

      • 14.6.1 Curemark LLC Company Details

      • 14.6.2 Curemark LLC Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Curemark LLC Alcohol Addiction Therapeutics Product and Service

    • 14.7 Omeros Corp

      • 14.7.1 Omeros Corp Company Details

      • 14.7.2 Omeros Corp Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Omeros Corp Alcohol Addiction Therapeutics Product and Service

    • 14.8 Kyorin Pharmaceutical Co Ltd

      • 14.8.1 Kyorin Pharmaceutical Co Ltd Company Details

      • 14.8.2 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product and Service

    • 14.9 Ethypharm SA

      • 14.9.1 Ethypharm SA Company Details

      • 14.9.2 Ethypharm SA Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ethypharm SA Alcohol Addiction Therapeutics Product and Service

    • 14.10 Opiant Pharmaceuticals Inc

      • 14.10.1 Opiant Pharmaceuticals Inc Company Details

      • 14.10.2 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product and Service

    • 14.11 Lohocla Research Corp

      • 14.11.1 Lohocla Research Corp Company Details

      • 14.11.2 Lohocla Research Corp Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Lohocla Research Corp Alcohol Addiction Therapeutics Product and Service

    • 14.12 Montisera Ltd

      • 14.12.1 Montisera Ltd Company Details

      • 14.12.2 Montisera Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Montisera Ltd Alcohol Addiction Therapeutics Product and Service

    • 14.13 Kinnov Therapeutics SAS

      • 14.13.1 Kinnov Therapeutics SAS Company Details

      • 14.13.2 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product and Service

    • 14.14 Indivior Plc

      • 14.14.1 Indivior Plc Company Details

      • 14.14.2 Indivior Plc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Indivior Plc Alcohol Addiction Therapeutics Product and Service

    • 14.15 Corcept Therapeutics Inc

      • 14.15.1 Corcept Therapeutics Inc Company Details

      • 14.15.2 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product and Service

    • 14.16 Heptares Therapeutics Ltd

      • 14.16.1 Heptares Therapeutics Ltd Company Details

      • 14.16.2 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product and Service

    • 14.17 AstraZeneca Plc

      • 14.17.1 AstraZeneca Plc Company Details

      • 14.17.2 AstraZeneca Plc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 AstraZeneca Plc Alcohol Addiction Therapeutics Product and Service

    • 14.18 H Lundbeck A/S

      • 14.18.1 H Lundbeck A/S Company Details

      • 14.18.2 H Lundbeck A/S Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 H Lundbeck A/S Alcohol Addiction Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Alcohol Addiction Therapeutics

    • Figure Alcohol Addiction Therapeutics Picture

    • Table Global Alcohol Addiction Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Alcohol Addiction Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Alcohol Addiction Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Alcohol Addiction Therapeutics Consumption by Country (2017-2022)

    • Figure United States Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Alcohol Addiction Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Alcohol Addiction Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Alcohol Addiction Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CM-1212 Consumption and Growth Rate (2017-2022)

    • Figure Global CTDP-002 Consumption and Growth Rate (2017-2022)

    • Figure Global A-705253 Consumption and Growth Rate (2017-2022)

    • Figure Global ABT-436 Consumption and Growth Rate (2017-2022)

    • Figure Global ADX-71441 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global CM-1212 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTDP-002 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global A-705253 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ABT-436 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ADX-71441 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Alcohol Addiction Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Alcohol Addiction Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Chronos Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Alcohol Addiction Therapeutics Product and Service

    • Table Cerecor Inc (Foundation Year, Company Profile and etc.)

    • Table Cerecor Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cerecor Inc Alcohol Addiction Therapeutics Product and Service

    • Table BioCorRx Inc (Foundation Year, Company Profile and etc.)

    • Table BioCorRx Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCorRx Inc Alcohol Addiction Therapeutics Product and Service

    • Table Bionex Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)

    • Table Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product and Service

    • Table Curemark LLC (Foundation Year, Company Profile and etc.)

    • Table Curemark LLC Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curemark LLC Alcohol Addiction Therapeutics Product and Service

    • Table Omeros Corp (Foundation Year, Company Profile and etc.)

    • Table Omeros Corp Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omeros Corp Alcohol Addiction Therapeutics Product and Service

    • Table Kyorin Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product and Service

    • Table Ethypharm SA (Foundation Year, Company Profile and etc.)

    • Table Ethypharm SA Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethypharm SA Alcohol Addiction Therapeutics Product and Service

    • Table Opiant Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product and Service

    • Table Lohocla Research Corp (Foundation Year, Company Profile and etc.)

    • Table Lohocla Research Corp Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lohocla Research Corp Alcohol Addiction Therapeutics Product and Service

    • Table Montisera Ltd (Foundation Year, Company Profile and etc.)

    • Table Montisera Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Montisera Ltd Alcohol Addiction Therapeutics Product and Service

    • Table Kinnov Therapeutics SAS (Foundation Year, Company Profile and etc.)

    • Table Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product and Service

    • Table Indivior Plc (Foundation Year, Company Profile and etc.)

    • Table Indivior Plc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Indivior Plc Alcohol Addiction Therapeutics Product and Service

    • Table Corcept Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product and Service

    • Table Heptares Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product and Service

    • Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc Alcohol Addiction Therapeutics Product and Service

    • Table H Lundbeck A/S (Foundation Year, Company Profile and etc.)

    • Table H Lundbeck A/S Alcohol Addiction Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table H Lundbeck A/S Alcohol Addiction Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US